Page last updated: 2024-08-16

risperidone and benzoxazoles

risperidone has been researched along with benzoxazoles in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kenny, PW; Toulmin, A; Wood, JM	1
Hemrick-Luecke, SK; Hsu, MA; Johnson, BG; Noone, S; Rasmussen, K; Thompson, LK	1
Casey, DE; Heisterberg, J; Sands, EE; Yang, HM	1
Auclair, AL; Barret-Grévoz, C; Barreto, M; Depoortère, R; Kleven, MS; Newman-Tancredi, A	1

Trials

1 trial(s) available for risperidone and benzoxazoles

Article	Year
Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study. Psychopharmacology, 2008, Volume: 200, Issue:3 Topics: Acute Disease; Adult; Antipsychotic Agents; Benzoxazoles; Body Weight; Cholesterol; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Electrocardiography; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Prolactin; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome; Triglycerides	2008

Article

Year

Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study.

Psychopharmacology, 2008, Volume: 200, Issue:3

Topics: Acute Disease; Adult; Antipsychotic Agents; Benzoxazoles; Body Weight; Cholesterol; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Electrocardiography; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Prolactin; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome; Triglycerides

2008

Other Studies

3 other study(ies) available for risperidone and benzoxazoles

Article	Year
Toward prediction of alkane/water partition coefficients. Journal of medicinal chemistry, 2008, Jul-10, Volume: 51, Issue:13 Topics: Alkanes; Central Nervous System; Molecular Structure; Static Electricity; Surface Properties; Water	2008
The orexin-1 antagonist SB-334867 blocks antipsychotic treatment emergent catalepsy: implications for the treatment of extrapyramidal symptoms. Schizophrenia bulletin, 2007, Volume: 33, Issue:6 Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Behavior, Animal; Benzodiazepines; Benzoxazoles; Catalepsy; Haloperidol; Intracellular Signaling Peptides and Proteins; Locomotion; Male; Naphthyridines; Neuropeptides; Olanzapine; Orexins; Prolactin; Rats; Rats, Sprague-Dawley; Risperidone; Urea	2007
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys. Behavioural brain research, 2009, Nov-05, Volume: 203, Issue:2 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Benzamides; Benzodiazepines; Benzoxazoles; Catalepsy; Clozapine; Dibenzothiazepines; Dioxanes; Dopamine Antagonists; Female; Haloperidol; Macaca fascicularis; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Remoxipride; Risperidone; Serotonin Receptor Agonists; Thiazoles; Tropanes; Video Recording	2009